CM
OYST

Crystalline Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Crystalline Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,421
Closed -$128K – 158
2022
Q4 		$128K Buy
+11,421
New +$128K 0.06% 107